Nanoveu (ASX:NVU) corrected its Dec. 12, 2024, statement to clarify that the US patent for an artificial intelligence-based vision technology exclusively licensed to its Emass subsidiary is still in the application stage, according to a March 21 filing with the Australian bourse.
The patent was published on Sept. 5, 2024, and the current status is "pending," the company said in the filing. The application was filed on March 1, 2024.
The company's shares dropped 8% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.